NASDAQ: DMRARUSSELL2000
Damora Therapeutics, Inc.
Healthcare · Biotechnology · Headquartered in Waltham, US
Price
Loading chart…
Overview
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Damora Therapeutics, Inc., its business model, key products, and controversies.